Soleno Therapeutics (SLNO) had the highest return between September 1, 2023 and January 31, 2024 by a US stock with a market cap of $2B+, returning 834.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Soleno Therapeutics (SLNO) | 9/1/2023 - 1/31/2024 | 834.48% |
QXO (QXO) | 9/1/2023 - 1/31/2024 | 250.26% |
Edgewise Therapeutics (EWTX) | 9/1/2023 - 1/31/2024 | 183.02% |
Summit Therapeutics (SMMT) | 9/1/2023 - 1/31/2024 | 141.98% |
Biohaven Pharmaceutical (BHVN) | 9/1/2023 - 1/31/2024 | 141.48% |
Trump Media & Technology (DJT) | 9/1/2023 - 1/31/2024 | 128.34% |
Scholar Rock (SRRK) | 9/1/2023 - 1/31/2024 | 122.84% |
Cytokinetics (CYTK) | 9/1/2023 - 1/31/2024 | 121.14% |
Crinetics Pharmaceuticals (CRNX) | 9/1/2023 - 1/31/2024 | 108.46% |
Immunitybio (IBRX) | 9/1/2023 - 1/31/2024 | 107.41% |
Vera Therapeutics (VERA) | 9/1/2023 - 1/31/2024 | 104.95% |
NewAmsterdam Pharma Company NV Ordinary Shares (NAMS) | 9/1/2023 - 1/31/2024 | 98.74% |
Oscar Health (OSCR) | 9/1/2023 - 1/31/2024 | 97.48% |
Alpha Metallurgical Resources (AMR) | 9/1/2023 - 1/31/2024 | 94.22% |
Affirm (AFRM) | 9/1/2023 - 1/31/2024 | 93.13% |
Super Micro Computer (SMCI) | 9/1/2023 - 1/31/2024 | 91.19% |
Abercrombie & Fitch (ANF) | 9/1/2023 - 1/31/2024 | 88.88% |
Flex (FLEX) | 9/1/2023 - 1/31/2024 | 88.65% |
Crowdstrike (CRWD) | 9/1/2023 - 1/31/2024 | 79.32% |
Pactiv Evergreen (PTVE) | 9/1/2023 - 1/31/2024 | 77.23% |
Compania de Minas Buenaventura SAA ADR (BVN) | 9/1/2023 - 1/31/2024 | 75.58% |
Uranium Energy (UEC) | 9/1/2023 - 1/31/2024 | 74.43% |
Wingstop (WING) | 9/1/2023 - 1/31/2024 | 73.94% |
Viking Therapeutics (VKTX) | 9/1/2023 - 1/31/2024 | 73.67% |
Arcellx (ACLX) | 9/1/2023 - 1/31/2024 | 72.21% |
